406 related articles for article (PubMed ID: 37870696)
21. Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
Ogino A; Choi J; Lin M; Wilkens MK; Calles A; Xu M; Adeni AE; Chambers ES; Capelletti M; Butaney M; Gray NS; Gokhale PC; Palakurthi S; Kirschmeier P; Oxnard GR; Sholl LM; Jänne PA
Mol Oncol; 2021 Jan; 15(1):27-42. PubMed ID: 32191822
[TBL] [Abstract][Full Text] [Related]
22. [Advances in Molecular Subtyping, Characteristics and Therapeutic Strategies of
Small Cell Lung Cancer].
Wu Y; Zhao J; Wang M
Zhongguo Fei Ai Za Zhi; 2023 Apr; 26(4):303-309. PubMed ID: 37183645
[TBL] [Abstract][Full Text] [Related]
23. Small cell lung cancer; recent advances of its biology and therapeutic perspective.
Hayashi R; Inomata M
Respir Investig; 2022 Mar; 60(2):197-204. PubMed ID: 34896039
[TBL] [Abstract][Full Text] [Related]
24. Predictive biomarkers for immunotherapy response in extensive-stage SCLC.
Zhu L; Qin J
J Cancer Res Clin Oncol; 2024 Jan; 150(1):22. PubMed ID: 38245636
[TBL] [Abstract][Full Text] [Related]
25. Personalized Therapy of Small Cell Lung Cancer.
Schneider BJ; Kalemkerian GP
Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
[TBL] [Abstract][Full Text] [Related]
26. Challenging the recalcitrant disease-developing molecularly driven treatments for small cell lung cancer.
Mak DWS; Li S; Minchom A
Eur J Cancer; 2019 Sep; 119():132-150. PubMed ID: 31445197
[TBL] [Abstract][Full Text] [Related]
27. Small-cell lung cancer: an update on targeted therapies.
Joshi M; Ayoola A; Belani CP
Adv Exp Med Biol; 2013; 779():385-404. PubMed ID: 23288650
[TBL] [Abstract][Full Text] [Related]
28. Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions.
Zhang C; Zhang C; Wang K; Wang H
J Transl Med; 2023 Jul; 21(1):468. PubMed ID: 37452395
[TBL] [Abstract][Full Text] [Related]
29. Holistic immunomodulation for small cell lung cancer.
Leung EL; Fan XX; Huang JM; Huang C; Lin H; Cao YB
Semin Cancer Biol; 2023 Jan; 88():96-105. PubMed ID: 36470543
[TBL] [Abstract][Full Text] [Related]
30. Update 2021: Management of Small Cell Lung Cancer.
Tariq S; Kim SY; Monteiro de Oliveira Novaes J; Cheng H
Lung; 2021 Dec; 199(6):579-587. PubMed ID: 34757446
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy versus standard chemotherapy for treatment of extensive-stage small-cell lung cancer: a systematic review.
Liu X; Xing H; Zhang H; Liu H; Chen J
Immunotherapy; 2021 Aug; 13(12):989-1000. PubMed ID: 34114477
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic modalities in small cell lung cancer: a paradigm shift after decades of quiescence.
El Sayed R; El Darsa H
Expert Opin Pharmacother; 2022 Apr; 23(5):583-597. PubMed ID: 35176957
[TBL] [Abstract][Full Text] [Related]
33. [Research Advances on Transformation to Small Cell Lung Cancer].
Zhang S; Li S; Cui Y; Cheng Y
Zhongguo Fei Ai Za Zhi; 2021 Oct; 24(10):729-733. PubMed ID: 34696545
[TBL] [Abstract][Full Text] [Related]
34. Targeted therapies for small cell lung cancer: Where do we stand?
Arcaro A
Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
[TBL] [Abstract][Full Text] [Related]
35. Small cell lung cancer: where do we go from here?
Byers LA; Rudin CM
Cancer; 2015 Mar; 121(5):664-72. PubMed ID: 25336398
[TBL] [Abstract][Full Text] [Related]
36. Use of Immunotherapy in Extensive-Stage Small Cell Lung Cancer.
Konala VM; Madhira BR; Ashraf S; Graziano S
Oncology; 2020; 98(11):749-754. PubMed ID: 32663833
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy-Regulated microRNA-125-HER2 Pathway as a Novel Therapeutic Target for Trastuzumab-Mediated Cellular Cytotoxicity in Small Cell Lung Cancer.
Yagishita S; Fujita Y; Kitazono S; Ko R; Nakadate Y; Sawada T; Kitamura Y; Shimoyama T; Maeda Y; Takahashi F; Takahashi K; Tamura T; Koizumi F
Mol Cancer Ther; 2015 Jun; 14(6):1414-23. PubMed ID: 25833836
[TBL] [Abstract][Full Text] [Related]
38. Poly(ADP-Ribose) Polymerase Inhibition in Small Cell Lung Cancer: A Review.
Guo MZ; Marrone KA; Spira A; Scott SC
Cancer J; 2021 Nov-Dec 01; 27(6):476-481. PubMed ID: 34904810
[TBL] [Abstract][Full Text] [Related]
39. Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer.
Yu L; Lai Q; Gou L; Feng J; Yang J
J Drug Target; 2021 Jan; 29(1):1-11. PubMed ID: 32700566
[TBL] [Abstract][Full Text] [Related]
40. Novel therapeutic strategies for recurrent SCLC.
Moliner L; Zhang B; Lamberti G; Ardizzoni A; Byers LA; Califano R
Crit Rev Oncol Hematol; 2023 Jun; 186():104017. PubMed ID: 37150311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]